Old Mission Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-262,659
| Closed | -$13.4M | – | 1220 |
|
|
2025
Q4 | $13.4M | Buy |
+262,659
| New | +$13.4M | 0.31% | 39 |
|
|
2025
Q1 | – | Sell |
-503,079
| Closed | -$43.3M | – | 1144 |
|
|
2024
Q4 | $43.3M | Buy |
+503,079
| New | +$54.4M | 0.66% | 16 |
|
|
2024
Q2 | – | Sell |
-41,209
| Closed | -$5.29M | – | 1562 |
|
|
2024
Q1 | $5.29M | Buy |
+41,209
| New | +$4.91M | 0.09% | 166 |
|
|
2023
Q4 | – | Sell |
-74,141
| Closed | -$6.74M | – | 1557 |
|
|
2023
Q3 | $6.74M | Buy |
+74,141
| New | +$6.53M | 0.15% | 133 |
|
|
2023
Q2 | – | Sell |
-75,810
| Closed | -$6.03M | – | 1481 |
|
|
2023
Q1 | $6.03M | Buy |
+75,810
| New | +$5.38M | 0.12% | 122 |
|
|
2022
Q4 | – | Sell |
-159,314
| Closed | -$7.94M | – | 1638 |
|
|
2022
Q3 | $7.94M | Sell |
159,314
-102,428
| -39% | -$5.49M | 0.25% | 62 |
|
|
2022
Q2 | $14.6M | Buy |
261,742
+134,672
| +106% | +$7.47M | 0.41% | 37 |
|
|
2022
Q1 | $7.06M | Buy |
+127,070
| New | +$6.52M | 0.2% | 71 |
|
|
2021
Q2 | – | Sell |
-83,102
| Closed | -$2.8M | – | 1180 |
|
|
2021
Q1 | $2.8M | Sell |
83,102
-446,670
| -84% | -$15.9M | 0.16% | 165 |
|
|
2020
Q4 | $18.5M | Buy |
+529,772
| New | +$18.3M | 1.14% | 15 |
|
|
2020
Q2 | – | Sell |
-895,802
| Closed | -$27M | – | 595 |
|
|
2020
Q1 | $27M | Buy |
895,802
+579,776
| +183% | +$17.3M | 2.29% | 6 |
|
|
2019
Q4 | $9.15M | Buy |
+316,026
| New | +$8.75M | 0.7% | 36 |
|
|
2019
Q3 | – | Sell |
-46,514
| Closed | -$1.19M | – | 302 |
|
|
2019
Q2 | $1.19M | Buy |
+46,514
| New | +$1.15M | 0.15% | 112 |
|
|
2019
Q1 | – | Sell |
-236,790
| Closed | -$5.45M | – | 305 |
|
|
2018
Q4 | $5.45M | Buy |
+236,790
| New | +$5.26M | 0.56% | 49 |
|
|
2018
Q3 | – | Sell |
-88,038
| Closed | -$2.03M | – | 318 |
|
|
2018
Q2 | $2.03M | Sell |
88,038
-40,492
| -32% | -$962K | 0.22% | 63 |
|
|
2018
Q1 | $3.17M | Buy |
+128,530
| New | +$3.37M | 0.42% | 43 |
|
|
2017
Q3 | – | Sell |
-194,024
| Closed | -$4.16M | – | 391 |
|
|
2017
Q2 | $4.16M | Sell |
194,024
-205,966
| -51% | -$4.16M | 0.51% | 42 |
|
|
2017
Q1 | $6.86M | Sell |
399,990
-1,163,118
| -74% | -$20.3M | 0.76% | 32 |
|
|
2016
Q4 | $28M | Buy |
1,563,108
+1,240,686
| +385% | +$22.5M | 2.15% | 5 |
|
|
2016
Q3 | $6.71M | Buy |
322,422
+275,316
| +584% | +$6.83M | 0.44% | 40 |
|
|
2016
Q2 | $1.27M | Sell |
47,106
-328,902
| -87% | -$9.02M | 0.09% | 120 |
|
|
2016
Q1 | $10.2M | Buy |
376,008
+278,366
| +285% | +$7.46M | 0.98% | 31 |
|
|
2015
Q4 | $2.84M | Sell |
97,642
-59,796
| -38% | -$1.66M | 0.36% | 56 |
|
|
2015
Q3 | $4.27M | Buy |
+157,438
| New | +$4.46M | 0.59% | 36 |
|
|
2015
Q2 | – | Sell |
-123,122
| Closed | -$3.29M | – | 269 |
|
|
2015
Q1 | $3.29M | Buy |
+123,122
| New | +$2.84M | 0.77% | 33 |
|
Other funds holding NVO
DAM
F
Old Mission Capital's NVO Position: Q1 2026 in Review
Old Mission Capital sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 262,659 shares — an estimated $13.4M sold.
Old Mission Capital first reported a position in NVO in Q1 2015 and held it in 25 quarters. The position peaked at $43.3M in Q4 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Old Mission Capital reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Old Mission Capital sold 262,659 Novo Nordisk shares in Q1 2026, an estimated $13.4M.
- Old Mission Capital first reported a position in Novo Nordisk in Q1 2015 and held it in 25 quarters.
- Old Mission Capital's Novo Nordisk position peaked at $43.3M in Q4 2024.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Old Mission Capital's 13F filing for Q1 2026, filed 15 May 2026.